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Metabolism is known for its intricate adjustments to 
meet the needs of an organism. Due to demands of  
adaptation, parasite metabolic pathways are greatly 
altered from those of their hosts. A key difference in 
metabolic pathways in Plasmodium spp, during the in-
tra-erythrocytic stages, pertains to energy metabolism 
with the absence of a major role for the mitochondria 
in adenosine triphosphate (ATP) generation. In most 
organisms there exists a tight link between nucleotide 
and energy metabolism. An important feature of 
purine nucleotide metabolism in Plasmodium falcipa-
rum is the absence of the de novo pathway, with 
purine requirements being completely met by the sal-
vage pathway. Presence of the enzymes adenylosucci-
nate lyase, adenylosuccinate synthetase and adenosine 
monophosphate (AMP) deaminase, involved in AMP 
metabolism, suggests the existence of a functional 
purine nucleotide cycle (PNC) in P. falciparum with 
fumarate, a tricarboxylic acid (TCA) cycle intermedi-
ate, and ammonia being the net output from the cycle. 
In the absence of a conventional TCA cycle, the fate of 
fumarate generated from PNC merits examination. In 
this review we cover ATP generation through glycoly-
sis, key features of the TCA cycle, the role of electron 
transport chain and the link between PNC and the  
mitochondrion. Recent studies using genetic appro-
aches highlight unexpected features that were hitherto 
unknown with respect to these pathways and these are 
also summarized in this review.  
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Introduction 
PLASMODIUM FALCIPARUM, the causative agent of cerebral 
malaria completes its life cycle in two hosts: mosquito 
and human. Growth and reproduction in two varied habi-
tats necessitates the adaptation of the organism to com-
pletely different environments. This has led to the 
evolution of metabolic pathways in the parasite that are 
optimized to utilize available nutrients in the two hosts1. 
The completion of the genome sequence has contributed, 
to a great extent, to our understanding of the metabolism 
in P. falciparum2, wherein several key differences are 
evident when compared to free-living organisms. No-
ticeably, P. falciparum lacks two key pathways, namely 
amino acid and purine nucleotide biosynthesis. Despite 
the presence of genes for the tricarboxylic acid (TCA) 
cycle enzymes and the mitochondrial electron transport 
chain (ETC) complexes, biochemical studies attribute 
glycolysis to being the key pathway for adenosine 
triphosphate (ATP) generation in intraerythrocytic (IE) 
parasites3. With the source of acetyl coenzyme A (acetyl-
CoA), the metabolite that initiates the TCA cycle, appar-
ently missing in the mitochondrion of Plasmodium spp, 
α-ketoglutarate, generated from glutamine, was observed 
to feed in and initiate a branched TCA pathway in the IE 
stages of the parasite4. Adenosine monophosphate (AMP) 
and guanosine monophosphate (GMP) synthesis in the IE 
stages is via the salvage of hypoxanthine and adenosine 
from the human host. AMP is synthesized from inosine 
monophosphate (IMP) by the sequential action of adeny-
losuccinate synthetase (ADSS) and adenylosuccinate 
lyase (ASL). AMP deaminase (AMPD) deaminates AMP 
back to IMP. The reactions catalysed by these three  
enzymes constitute the purine nucleotide cycle (PNC). 
Figure 1 shows a schematic representation of PNC that 
comprises the enzymes ADSS, ASL and AMPD. In exer-
cising skeletal muscles, the fumarate generated from PNC 
feeds into the TCA cycle and contributes to increase in 
ATP levels5. However, the role of PNC in P. falciparum 
is not fully understood. In this review we provide an 
overview of the literature on mitochondrial pathways, 
purine nucleotide metabolism and hypothesize on the link 
between the two in P. falciparum.  
Glycolysis in P. falciparum  
It was observed that P. falciparum-infected erythrocytes 
take up 100 times more glucose than the uninfected eryth-
rocytes6. The increased consumption is attributed to both 
the transporters and the enzymes of the parasite com-
partment. The glucose uptake is through a high-affinity
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Figure 1. Purine nucleotide cycle (PNC). The enzymes and three reactions involved in the cycle are shown. The 
accession numbers correspond to the enzymes from Plasmodium falciparum. One molecule each of fumarate,  
ammonia and inorganic phosphate are the net products formed from the complete operation of the cycle. The sub-
strate consumed in the process is shown in red and net products formed are shown in green. SAMP, Succinyl-
AMP; AMP, adenosine monophosphate; IMP, inosine monophosphate. 
 
 
facilitative hexose transporter (PfHT)7. The transporter is 
expressed throughout the lifecycle of the parasite and 
through the use of inhibitors it has been shown to be  
essential for the intraerythrocytic parasite development8. 
Unlike the human glucose transporter, glut1, which is 
highly specific for glucose, PfHT can take in fructose as 
well7. This differential substrate specificity has enabled 
the design of drugs which specifically target the parasite 
transporter9. Furthermore, the key regulatory enzymes of 
glycolysis, hexokinase and phosphofructokinase are  
reported to have low Km values for their substrates10. A 
thorough study on the mechanism of enhanced glycolytic 
flux is still missing. Metabolic labelling studies show that 
bulk of the glucose is metabolized to lactate11–13. The  
enzyme lactate dehydrogenase (LDH) is essential for the 
parasite and is highly expressed14. The crystal structure of 
this enzyme shows differences from that of the host sug-
gesting functional distinctions14,15. One of the key func-
tional differences is that unlike LDH from other 
organisms, the plasmodial enzyme is not inhibited by 
high concentrations of pyruvate, an adaptation reflective 
of the microaerophilic nature of the organism16. The con-
version of pyruvate to lactate enables the oxidation of  
reduced nicotinamide adenine dinucleotide (NADH), 
thereby providing sufficient nicotinamide adenine dinu-
cleotide (NAD+) for the continuous operation of glycoly-
sis. Interestingly, glycerol was found to be one of the 
metabolites formed from glucose in the IE parasite11. This 
implies the possible presence of a functional glycerol-3-
phosphate shuttle in P. falciparum and that the parasite 
has alternate mechanisms to reoxidize cytosolic NADH. 
However, the enzymes involved in the formation of glyc-
erol are not known. Lian et al.11 have suggested the role 
of glycerol 3-phosphatase (unannotated) or glycerol 
kinase, operating in the reverse direction (thermodynami-
cally unfavourable) as in trypanosomes17,18, as probable 
enzymes involved in the formation of glycerol. An alter-
native explanation suggests that a non-specific acid phos-
phatase can act upon glycerol 3-phosphate and form 
glycerol19. Further experimentation would probably high-
light the metabolic significance of glycerol production in 
the parasite.  
Source of acetyl CoA and TCA cycle  
The absence of incorporation of label from glucose into 
TCA cycle intermediates11,12,20 implies that glycolysis  
is disconnected from the TCA cycle in the parasite. This is 
further supported by the finding that the pyruvate dehy-
drogenase (PDH) complex in P. falciparum localizes to 
the apicoplast21,22 and not to the mitochondrion. Pei et 
al.23 showed that deletion of the E1α or E3 subunit genes 
of the PDH complex in the rodent malaria parasite, Plas-
modium yoelii caused no defect in blood, mosquito or 
early liver stage development. However, the knockout 
parasites could not initiate the blood-stage infection as 
they were unable to develop into exo-erythrocytic mero-
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zoites. This phenotype is similar to that observed for  
deletion of genes involved in type II fatty acid synthesis 
(FAS II)24,25. Thus, these results indicate that the sole role 
of PDH is probably to provide acetyl-CoA for FAS II 
rather than the TCA cycle.  
 β-Oxidation pathway of fatty acids in the mitochondria 
is another potential source of acetyl-CoA, but the genes 
for this metabolic process have not been annotated in any 
of the Plasmodial genomes sequenced thus far2,26. Other 
sources of acetyl-CoA are branched-chain ketoacid dehy-
drogenase complex and carnitine acetyl transferase.  
The annotated genome of P. falciparum does not have all  
the components necessary for the complete conversion of  
ketoacids to acetyl-CoA27. Though an annotation for  
carnitine acetyl transferase is missing, carnitine has been 
shown to provide growth support for erythrocyte-free 
parasites in culture28. Whether the growth advantage is 
due to the activity of carnitine acetyl transferase is yet  
to be tested. Thus, the parasite mitochondrion seems to be 
devoid of acetyl-CoA to fuel the TCA cycle.  
 Examination of the fate of added 13C-glutamine by  
liquid chromatography–mass spectrometry (LC–MS) 
analysis showed that the TCA cycle in P. falciparum is 
branched with α-ketoglutarate feeding in and initiating 
the pathway4. Although this seminal discovery has put an 
end to the long standing controversy about the existence 
of this pathway, it has fuelled more queries about its  
nature and essentiality. The added glutamine must be 
converted to α-ketoglutarate through glutamate. The con-
version of glutamine to glutamate can be brought about 
by various amidotransferases (e.g. carbamoyl phosphate 
synthetase, GMP synthetase, glutamine : oxoglutarate 
amidotransferase, etc.) that are present and expressed 
during the IE stages of the parasite2,29–31. Glutamate  
dehydrogenase (GDH) or aminotransferases were specu-
lated to facilitate the subsequent conversion of glutamate 
to α-ketoglutarate. However, in a recent report by Storm 
et al.32, using gdha knockout strain of Plasmodium berg-
hei, the non-involvement of this gene in the generation of 
α-ketoglutarate was shown. Also, through the use of the  
inhibitor L-cycloserine, it was shown that alanine and  
asparatate aminotransferases are also not involved in  
facilitating this conversion32. In this context a study on 
the role of GDHb and GDHc in generating α-ketoglu-
tarate is warranted.  
 The NADP-dependent isocitrate dehydrogenase (IDH) 
catalyses the first reaction in the reductive branch of the 
non-canonical TCA pathway4. The reaction is reversible 
and the ratio of NADP+: NADPH in the mitochondrion  
determines the direction of the reaction, with lower ratios 
favouring the reductive reaction. Glutamate dehydro-
genase (GDH) was thought to be a major source of 
NADPH in the parasite. With the generation of a viable 
GDHa– strain32, an alternate source of NADPH must be 
present to drive the reductive reaction of IDH. The alter-
nate source of NADPH could be pyridine transhydro-
genase or GDHc. An earlier study by Wrenger and 
Muller33 has provided kinetic parameters for IDH catalys-
ing the oxidative reaction. However, the kinetic features 
of the reductive reaction catalysed by this enzyme have 
not been examined. Other aspects of the branched TCA 
pathway such as: (1) the enzyme for the conversion of 
citrate to oxaloacetate (OAA) and acetyl-CoA (attributed 
to ATP-dependent citrate lyase activity in the erythrocyte 
cytosol) and (2) transporters for acetyl-CoA in mitochon-
dria are still unclear. Though some functional aspects 
such as source of succinyl-CoA, guanosine triphosphate 
(GTP) and acetyl-CoA have been attributed to this 
branched pathway, their essentiality in different stages of 
the parasite life cycle has to be validated by gene knock-
out studies.  
The role of mitochondrion in P. falciparum  
Plasmodium species during the intraerythrocytic phase of 
their life cycle are known to possess a single mitochon-
drion. The mitochondrion among plasmodial spp. is hetero-
genous with respect to size, shape, behaviour upon 
subcellular fractionation, extent of internal structures, 
etc.34–37. Obvious differences are the extent of oxidative 
phosphorylation and the alternative oxidase activity in 
different species. Rodent parasites, P. yoelii and P. berg-
hei seem to have a higher rate of oxidative phosphoryla-
tion compared to P. falciparum35–37. Unlike other species 
in the genus, P. falciparum is reported to have an alterna-
tive oxidase activity38.  
 Though mitochondria underwent a reductive evolution 
in apicomplexan spp, their role seems to be essential for 
the survival of the parasites. The essentiality of this or-
ganelle is due to the many functions it performs, viz. (1) 
it is the source of succinyl-CoA essential for heme bio-
synthesis; (2) it is the source of orotate, an intermediate 
in de novo pyrimidine synthesis39 and (3) iron sulphur 
cluster biosynthesis27, which is essential for the activity 
of many enzymes. Though validated as a drug target for 
malaria, a clear understanding of the various functional 
aspects of the mitochondrion in P. falciparum is still 
lacking. Earlier studies have demonstrated that glycolysis 
and ETC are uncoupled and there is little, if any, ATP 
contribution by oxidative phosphorylation40. Neverthe-
less, mitochondrial membrane potential has been proven 
to be an essential component for the survival of the para-
site in the intraerythrocytic stages. The role of the mem-
brane potential apart from being vital for respiration is 
also implicated in the transport of small molecules and 
proteins across the inner mitochondrial membrane27. 
Electron transport chain  
P. falciparum has all the five respiratory complexes, 
though they are different from those of the mammalian 
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mitochondria. Complex I is rotenone insensitive and  
non-proton pumping and belongs to class II NADH dehy-
drogenase41. Complex II comprising succinate dehydro-
genase converts succinate to fumarate. The earlier 
proposed quinol fumarate reductase activity (which  
converts fumarate to succinate) in the IE stages has been 
disproved by various metabolic labelling studies in the 
recent literature4,42. Moreover, the enzyme isolated from 
P. yoelii behaves similar to the human enzyme and gets 
inhibited by atpenin, a mammalian complex II inhibitor34. 
Complex III, the cytochrome bc1 complex (proton pump-
ing), is the only complex which generates oxidized 
ubiquinone that is essential for the activity of many mito-
chondrial dehydrogenases. Various classes of inhibitors 
like naphthoquinones, pyridines, acridones, aridinediones 
and quinolones target the Q0 site of complex III, resulting 
in collapse of the membrane potential43–45. Complex IV 
which consists of cytochrome c oxidase (proton pumping) 
is sensitive to cyanide inhibition46–48. Complex V in the 
parasite is still not well characterized, though recent  
bioinformatic analysis provides annotation for all sub-
units of the F1 and F0 complexes49. For details about these 
complexes, the reader may refer elsewhere27,50–53.  
 Total mitochondrial membrane potential, Δp, is the 
sum of the potential contributed by ΔpH (difference in 
concentration of H+ ions) and ΔpΨ (electron transfer  
potential). Complexes III and IV, that are proton pumping 
contribute to ΔpH, whereas complexes I to IV contribute 
to ΔpΨ. The contribution from alternative oxidase in P. 
falciparum is still not validated though 25% of the O2 
consumption is attributed to alternative oxidase activity38. 
Other components like the ATP/adenosine diphosphate 
(ADP) translocator are also hypothesized to contribute 
through ΔpH to the membrane potential53. The relative 
contribution of these components to total mitochondrial 
membrane potential is still not determined in any Plas-
modium spp.  
Mitochondrial dehydrogenases and their essentiality  
There are at least four dehydrogenases, viz. NADH dehy-
drogenase (complex I), succinate dehydrogenase (com-
plex II), dihydroorotate dehydrogenase (DHODH) and 
glycerol 3-phosphate dehydrogenase associated with  
the mitochondrion of Plasmodium35,41,49,54. In addition, the 
parasite also has a malate dependent quinone oxido-
reductase (MQO)37. DHODH, which catalyses the con-
version of dihydroorotate to orotate, is an essential en-
zyme involved in pyrimidine biosynthesis. It belongs to 
type 2 class of DHODH and is dependent on the avail-
ability of oxidized ubiquinone for its function and hence, 
is dependent on complex III for its activity. Supplement-
ing the parasite with yeast DHODH (yDHODH), a type 1 
fumarate-dependent DHODH, makes the parasite resis-
tant to atovaquone, a ubiquinone analogue that inhibits 
complex III by binding to cytochrome b subunit.  
However, different strains of transgenic P. falciparum 
expressing yDHODH from a single copy of the gene  
integrated into their genome show variation in suscepti-
bility to atovaquone55. This unexpected finding suggests 
that there is a strain-dependent variation in the essential-
ity of dehydrogenases other than DHODH. In this con-
text, there is a need for gene knockout studies to 
conclusively prove the role of these dehydrogenases in 
different strains of the parasite. The non-proton pumping 
complex I in P. falciparum referred to as NADH dehy-
drogenase 2 (NDH2), has been claimed to be essential 
based on in vitro inhibition of the parasite by various  
inhibitors41,56. In fact, extensive efforts have been put  
towards development of inhibitors directed to the inhibi-
tion of P. falciparum NDH2 activity. However, a recent 
study excluded the essentiality of NDH2 in P. berghei57. 
Knockout of NDH2 in P. berghei showed that the strain 
was viable with an intact mitochondrial membrane poten-
tial and normal virulence. However, NDH2-deficient 
strains were not able to undergo sporogony in the mos-
quito stages and showed arrest at the ookinete stage 
though mitochondrial membrane potential in this stage 
was not lost. The authors suggest that processes involving 
high ATP requirement in the parasite during oocyst  
development, such as organelle disposal, are severely  
affected.  
Alternate oxidase 
Cyanide-independent respiration in P. falciparum sug-
gests the existence of alternate oxidase38. That atova-
quone does not completely collapse the mitochondrial 
membrane potential indicated that a portion of the mem-
brane potential is insensitive to atovaquone treatment39. 
Proguanil, a dihydrofolate reductase (DHFR) inhibitor 
was however able to collapse this potential by an  
unknown mechanism58. It has been reported that alternate 
oxidase inhibitors, salicylhydroxamic acid (SHAM) and 
propyl gallate, potentiate the activity of atovaquone59. A 
recent study has examined the proteomic changes in P. 
falciparum caused by treatment with SHAM60. Upon drug 
treatment, among other changes observed, a key change 
was seen in upregulation of the levels of some glycolytic 
enzymes. Alternate oxidase from plants is well character-
ized and the enzyme is active as a homodimer. It is 
known that organic acids (like pyruvate) allosterically ac-
tivate alternative oxidase by promoting its dimerization61. 
Increased pyruvate formation upon activation of glycoly-
sis, is suggested to counteract the inhibitory effect of 
SHAM in P. falciparum. It was also observed that under 
hyperoxic conditions there was a dramatic drop in the  
inhibitory concentration (IC50) of SHAM, suggesting that 
the metabolic adaptation to oxygen-rich environment is 
sensitive to SHAM. However, sequences with homology 
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to altenate oxidases from other organisms have not been 
identified in P. falciparum.  
Apicoplast and mitochondrial connection  
The apicoplast and the mitochondrion in P. falciparum 
are always seen to lie in close contact with each other. 
Hence, transport of metabolites across these organelles 
was hypothesized62. The key pathways in apicoplast are 
type II fatty acid biosynthesis, iron sulphur cluster bio-
synthesis, isoprenoid biosynthesis and a portion of heme 
biosynthesis. Using a chemical genetics approach, Yeh 
and Derisi63 have shown that isoprenoid biosynthesis is 
probably the only key function of the apicoplast. Inhibi-
tion with the antibacterial agent, fosmidomycin that tar-
gets isoprenoid biosynthesis was shown to be overcome 
by supplementing the parasite cells with isopentenyl  
pyrophosphate (IPP). The IPP-rescued parasites seemed 
to be devoid of the apicoplast, while the mitochondrion 
was intact as evident by the measurement of mitochon-
drial/nuclear DNA ratio and Mito Tracker staining. In 
this context, it will be interesting to examine the meta-
bolic activities in the mitochondrion in the absence of 
apicoplast, as the two organelles are closely associated in 
the parasite. The susceptibility of transgenic P. falcipa-
rum strain expressing yDHODH (fumarate-dependent and 
ubiquinone-independent) to fosmidomycin suggests that 
IPP apart from serving as precursor for menaquinone/ 
ubiquinone biosynthesis, might serve other essential 
roles. However, it is not possible to rule out the necessity 
of ubiquinone requirement for other dehydrogenases. 
This study also shows that apicoplast-generated acetyl-
CoA is not essential for the parasite survival, though it 
might be compensated for by the mitochondrial acetyl-
CoA. This needs further investigation.  
Purine nucleotide metabolism in P. falciparum  
The purine and pyrimidine requirements of the parasite 
are met by dedicated pathways in the organism. The 
purines are salvaged from the host2,64, whereas the 
pyrimidines are synthesized de novo in the parasite20. 
Flux balance analysis of P. falciparum metabolic network 
showed that the purine salvage pathway and its enzymes 
are essential for parasite survival65. Most of the enzymes 
in the purine salvage pathway have been biochemically 
and kinetically characterized66–68. The main source of 
purine in the intraerythrocytic stages of P. falciparum is 
adenosine and hypoxanthine. Once taken into the parasite 
cytosol, adenosine is converted to inosine and thereafter 
to hypoxanthine by sequential action of the essential  
enzymes, adenosine deaminase and purine nucleoside 
phosphorylase69–72. The hypoxanthine generated is con-
verted to IMP by the action of hypoxanthine guanine 
phosphoribosyltransferase (HGPRT). IMP is the nodal 
point from where both AMP and GMP are synthesized. 
AMP is generated by the sequential action of ADSS and 
ASL. The AMP generated is also converted back to IMP 
by the action of AMPD, as shown by the incorporation of 
33P into IMP when parasites are fed with [33P]–AMP73. 
This pathway of conversion of IMP to succinyl-AMP  
(S-AMP) and further to AMP that is converted back to 
IMP constitutes the PNC. All the enzymes involved in the 
PNC are expressed during the intraerythrocytic stages of 
the parasite30. The stoichiometry of the cycle is such that 
for every molecule of aspartate and GTP consumed, the 
net products formed are: (1) one molecule of fumarate, 
(2) one molecule of GDP and inorganic phosphate, and 
(3) one molecule of ammonia. The presence of PNC in  
P. falciparum suggests the need for regulation of AMP 
levels, and a possible role for fumarate and ammonia in 
parasite metabolism.  
 Examination of the annotated genome databases of 
various apicomplexans permitted the comparison of AMP 
metabolism and the possible existence of PNC in these 
organisms. A list of genes related to PNC in various api-
complexans is provided in Table 1. Interestingly, the 
complete PNC is present in Toxoplasma gondii, Neospora 
caninum, Eimeria tenella and all species of Plasmodium. 
Though ADSS and ASL are absent in Cryptosporidium, 
AMPD is present and AMP formation is catalysed by 
adenosine kinase from the precursor adenosine74. The 
presence of AMPD in this organism suggests that regula-
tion of AMP levels is critical and the ammonia generated 
may have metabolic significance. Theileria and Babesia, 
on the other hand, possess ADSS and ASL, but lack 
AMPD. In these organisms the fate of fumarate generated 
is an aspect that warrants investigation.  
 
Table 1. Summary of the enzymes of purine nucleotide cycle present  
  in apicomplexansa 
Organism  ADSS  ASL  AMPDA  
 
Cryptosporidium parvum  –b  –  √c  
Cryptosporidium hominis  –  –  √  
Cryptosporidium muris  –  –  √  
Plasmodium falciparum  √  √  √  
Plasmodium vivax  √  √  √  
Plasmodium yoelii  √  √  √  
Plasmodium berghei  √  √  √  
Plasmodium chabaudi  √  √  √  
Plasmodium knowlesi  √  √  √  
Toxoplasma gondii  √  √  √  
Neospora caninum  √  √  √  
Eimeria tenella  √  √  √  
Theileria annulata  √  √  –  
Theileria parva  √  √  –  
Babesia bovis  √  √  –  
aSequence search was done using BLAST in the in NCBI protein data-
base. The retrieved hits were confirmed in EupathDB and GeneDB  
database. The sequence of P. falciparum 3D7 (AMPD, ADSS, ASL) 
were used as BLAST query; bAbsence of protein homologue; 
c√Presence of protein homologue. AMPD, AMP deaminase; ADSS, 
adenylosuccinate synthetase; ASL, adenylosuccinate lyase. 
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Figure 2. Scheme showing the fate of fumarate in P. falciparum. Fumarate produced in the cytosol by PNC is 
shuttled into the mitochondrion where it is converted into oxaloacetate (OAA) through the involvement of  
fumarate hydratase (FH) and malate quinone oxidoreductase (MQO). The OAA transported into the cytosol 
serves as the precursor for aspartate and pyruvate. C I-V, Complex I–V; MQO, malate quinone oxidoreductase; 
AAT, aspartate aminotransferase; LDH, lactate dehydrogenase; PEPCK, phosphoenol pyruvate carboxykinase; 
PK, pyruvate kinase; PNC, purine nucleotide cycle; FH, fumarate hydratase. 
 
 
Fate of fumarate generated by PNC in P. falciparum  
Protozoan parasites are known to secrete organic acids 
such as lactate, malate, succinate, fumarate, etc.75. Through  
the use of 14C-labelled aspartate, recent studies have 
shown that fumarate generated through PNC is not  
secreted as a metabolic waste in the IE stages of P. falci-
parum42. Using intraerythrocytic in vitro cultures of P. 
falciparum, 13C-labelled fumarate (2,3-13C fumarate) 
supplemented in the medium was shown to be metabo-
lized to pyruvate and aspartic acid42. The pathway for 
fumarate metabolism is shown in Figure 2. As shown in 
the figure, the key intermediate for both aspartic acid and 
pyruvate formation, from fumarate, is OAA. The fumarate 
hydratase activity which brings about conversion of  
fumarate to malate has been shown to be localized to the 
mitochondrion in the parasite. The subsequent conversion 
of malate to OAA by MQO was validated through the use 
of atovaquone. Atovaquone-treated parasites failed to  
accumulate 13C-labelled aspartate, suggesting the role of 
mitochondrial MQO and not cytosolic malate dehydro-
genase in the generation of OAA from malate. The con-
version of OAA to aspartate is brought about by aspartate 
aminotransferase (AAT). Recombinant P. falciparum 
AAT has been shown to catalyse the reaction efficiently 
in both directions and localize to the cytosol42,76. The 
conversion of OAA to pyruvate must be through phos-
phoenolpyruvate carboxykinase (PEPCK) followed by 
pyruvate kinase. This conversion of fumarate to aspartic 
acid and pyruvate is compartmentalized between the mi-
tochondrion and the cytosol. The whole process therefore, 
requires the operation of shuttles that transport fumarate 
into the mitochondria and OAA out from this organelle.  
Significance of PNC in P. falciparum  
Schematically shown in Figure 3 are the possible roles 
for fumarate and ammonia generated by PNC and their 
crosstalk with other pathways in P. falciparum. Major 
role of PNC has been attributed to meeting the increased 
ATP demand and/or maintaining acid–base homeostasis 
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Figure 3. Crosstalk of PNC with other metabolic pathways in P. falciparum. Numbers 1–3 in PNC refer to the metabolites inosine monophos-
phate (IMP), SAMP and adenosine monophosphate (AMP) respectively. Brown arrows, enzymatic reactions in cytosol; grey arrows, enzymatic  
reactions in mitochondrion; orange arrows, transport processes; broken green arrows, possible role of metabolites (enzyme substrates or regulators); 
violet boxes, enzymes catalysing the reaction; lightning bolt, electron donation to ubiquinone; red filled circles, ubiquinone molecules and chevron 
arrows, directionality of the reaction. PEPC, Phosphoenolpyruvate carboxylase; ADA, adenosine deaminase; PNP, purine nucleoside phosphory-
lase; HGPRT, hypoxanthine guanine phosphoribosyltransferase; AK, adenylate kinase. Expansions for the remaining abbreviations are provided in 
the legend to Figures 1 and 2. 
 
 
in the cell. This is achieved by three ways, viz. by shift-
ing the equilibrium of adenylate kinase, by altering the 
flux of metabolites through TCA cycle reactions and by 
the release of ammonia. Adenylate kinase directly regulates 
the ATP pool and the directionality of the reaction cata-
lysed by this enzyme is sensitive to levels of AMP77,78. In 
PNC, AMPD acts on AMP and converts it back to IMP, 
thereby depleting the AMP pool within the cell. This will 
shift the adenylate kinase reaction towards ATP produc-
tion. Indeed, in rapidly dividing cancer cells there is an 
upregulation of PNC leading to a shift in the equilibrium 
of the adenylate kinase reaction towards ATP synthesis79. 
 PNC is also known to be upregulated in the skeletal 
muscles during exercise80,81. The fumarate generated in 
this cycle anaplerotically feeds the TCA cycle and 
thereby contributes to the increased ATP requirement 
during exercise82. In IE stages of P. falciparum, fumarate 
is recycled to aspartate and pyruvate (Figure 3). Malate, 
the first product of fumarate metabolism, is seen to be  
secreted as waste as well as utilized by the parasite to 
generate OAA4,42. A recent report by Storm and Muller83 
has shown that knockout of PEP carboxylase (PEPC) (the 
reaction catalysed by PEPC is the reverse of PEPCK) is 
conditional to supplementing the medium with millimolar 
concentrations of malate. The mechanism by which the 
activity of PEPC becomes essential has been attributed to 
the production of OAA.  
 OAA forms a metabolic node from which other reac-
tions can take place. One of the metabolites that can be 
formed from OAA is aspartate involving the enzyme  
aspartate aminotransferase (AAT). A recent study using 
P. falciparum AAT-specific peptide inhibitors has shown 
the essentiality of the enzyme activity for parasite 
growth76. The asparate formed can be used for protein 
and pyrimidine biosynthesis and this is evident by the in-
corporation of radioactivity in parasite protein and DNA 
fractions when incubated with [2,3-14C fumarate]. This 
could also serve as a mechanism by which purine nucleo-
tide metabolism regulates pyrimidine nucleotide synthesis 
in the parasite. Additionally, aspartate regeneration from 
fumarate (produced through PNC) is a likely to be impor-
tant in P. falciparum, as amino acid biosynthesis is absent 
in the parasite. In cancer cells, increased flux through 
PNC results in a net anabolic contribution. Deamidation 
of glutamine to glutamate and subsequent formation of 
aspartate by aspartate aminotransferase has been reported 
in many forms of cancer. The aspartate thus formed fuels 
the PNC in these cells84,85.  
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 Further, OAA can also be converted to lactate by the 
sequential action of PEPCK, pyruvate kinase and lactate 
dehydrogenase. The net result of these reactions is  
the oxidation of one molecule of NADH to NAD+ in the  
cytosol. The NAD+ formed can fuel the step catalysed by 
glyceraldehyde 3-phosphate dehydrogenase in the glyco-
lytic pathway and also feed into other pathways too.  
 Ammonia assimilation is suggested to be present in the 
parasite32 and hence the ammonia generated through PNC 
can be used for such reactions. However, it should be 
noted that a considerable amount of ammonia is secreted 
as a metabolic waste by the parasite86. In yeast, ammonia 
is reported to have a regulatory role in glycolysis by act-
ing as an allosteric activator of PFK87,88 and the extent of 
its regulatory activities in P. falciparum is yet to be  
examined. The temporal separation of fumarate and  
ammonia-generating reactions of PNC has been sug-
gested to be involved in pH regulation in the skeletal 
muscles of rainbow trout89. The exact nature of PNC in 
terms of temporal separation of its reactions and its role 
in pH maintenance is yet to be validated in the parasite.  
Conclusion  
Measurement of fluxes operating through interconnected 
pathways would provide a deeper understanding into the 
regulation of the pathways and the channelling of  
metabolites through them. The PNC plays a regulatory 
role in energy metabolism and maintenance of acid–base 
homeostasis. Due to the parasitic nature of P. falciapa-
rum, the regulatory processes of its metabolic pathways 
may be different from those of free-living organisms. The 
individual fluxes of each of the reactions of PNC along 
with their temporal regulation across the different stages 
are yet to be examined. The essentiality of fumarate  
generated through PNC and the reaction intermediates it 
generates have to be examined by the generation of con-
ditional knockouts of the genes of the cycle. Analysis of 
isotopomer distribution of labelled substrates using  
specific PNC knockout strains would permit evaluation of 
the fluxes operating through these pathways.  
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